| Literature DB >> 33201252 |
Fei Meng1,2,3, Naitong Sun4, Dongyan Liu1,2,3, Jia Jia1,2,3, Jun Xiao5, Haiming Dai6,7.
Abstract
BCL2L13 is a BCL2-like protein. It has been discovered for two decades, now on the way to be a hotspot of research with its physiological and pathological meanings found in recent years. Start with the pro-apoptotic activity, there have been reported consecutively that BCL2L13 could also induce mitochondrial fragmentation, inhibit cell death and promote mitophagy. Similar to BNIP3, BCL2L13 cannot be indiscriminately categorized into pro- or anti-apoptotic proteins. It anchors in the mitochondrial outer membrane, and expresses in various cells and tissues. This article reviews for the first time that BCL2L13 functions in physiological processes, such as growth and development and energy metabolism, and its dysregulation participating in pathological processes, including cancer, bacterial infection, cardiovascular diseases and degenerative diseases, suggesting its important roles in these events.Entities:
Keywords: Apoptosis; Autophagy; BCL-rambo; Cerebrovascular accident; Neurodegenerative disorders; Tumor
Mesh:
Substances:
Year: 2020 PMID: 33201252 DOI: 10.1007/s00018-020-03702-9
Source DB: PubMed Journal: Cell Mol Life Sci ISSN: 1420-682X Impact factor: 9.261